MENU
ROIV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Roivant Sciences (ROIV) Ownership - Who owns Roivant Sciences?
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more
Profile
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.19B
P/E Ratio
1.97
Total Cash
5.15B
Projected Growth
N/A
Total Debt
100.31M
Revenue
122.59M
Risk (Beta)
1.09
Dividend Yield
N/A
Total Cash/Share
7.21
Total Debt/Equity
N/A
Revenue/Share
0.16 USD as % of share price
Fundamentals
ROIV
Capitalization
7.19B
P/E Ratio
1.97
Risk (Beta)
1.09
Dividend Yield
N/A
Total Cash
5.15B
Total Cash/Share
7.21
Total Debt
100M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.16%
Revenue
123M
ROE
N/A
Book Value
5.19B
P/B Ratio
1.35
Cash Flow
N/A
Earnings
-0.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
37.91
Current Revenue Per Employee
9931.72
Dividends Per Share - Security
N/A
EBITDA
4.1B
Float
N/A
Float - Current
N/A
Gross Income Margin
97.13
Revenue To Assets
-1.78
Shares Held By Institutions
10.9B
Shares Outstanding - Current
714M
Total Liabilities
256M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-14.793
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A